Participate in the Avoca Group's Clinical Outsourcing Survey
Industry professionals are asked to participate in the annual Avoca Industry Survey, The State of Clinical Outsourcing, which explores outsourcing relationships, trends, practices, and approaches, and in particular, how these vary according to the type and size of company.
The survey takes approximately 15 to 20 minutes to complete. All responses are confidential and individual names will not be associated with results. The Avoca Group will express its thanks for your participation by sending you a complimentary copy of the Executive Summary, upon its release. Our findings will be presented at numerous industry conferences and will be published as well.
Please click here to take the survey.
We are pleased to have been asked to present select data gathered from this survey at IIR’s Clinical Biotech Forum, which is being held concurrently with the Partnerships In Clinical Trials meeting. For more information about IIR’s Clinical Biotech Forum West, click here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
